Pancreatic Cancer Clinical Trials and Treatments

Let's Win Pancreatic Cancer
Let's Win Pancreatic Cancer
403 بار بازدید - پارسال - Pancreatic cancer is notorious as
Pancreatic cancer is notorious as a cancer that is diagnosed late and is difficult to treat. In fact, it is poised to become the second leading cause of cancer deaths by 2030. Because of this, Let’s Win and the National Alliance for Hispanic Health’s Nuestras Voces program have teamed up for a series of hour-long Let’s Learn webinars to help you understand more about pancreatic cancer.

This webinar focuses on Treatment and Clinical Trials. Dr. Kim A. Reiss and Dr. Jose G. Trevino discuss the different treatment options and the importance of participating in clinical trials. The moderator is health advocate Daniel G Garza.

About 62,000 people are found to have pancreatic cancer each year in the U.S.; the rate of occurrence is slightly higher in Black Americans. The five-year survival rate for pancreatic cancer is about 11 percent, in part because the disease is often diagnosed at an advanced stage. The tumors are not found on a physical exam and the symptoms mimic many other more common conditions.

By learning more about treatment options and the importance of clinical trials, healthcare professionals can guide patients to the most effective treatments.
پارسال در تاریخ 1401/11/11 منتشر شده است.
403 بـار بازدید شده
... بیشتر